[Antigliadin, antireticulin, antiendomysium antibodies: value in the diagnosis and follow-up of celiac disease in children].
In recent years, the clinical spectrum of coeliac disease has changed and forms with mild aspecific symptoms are today frequent. Therefore many infants are submitted to jejunal biopsy in order to exclude coeliac disease or to allow an early diagnosis. This has led to a search for a simple and reliable diagnostic test of coeliac disease in order to limit the use of jejunal biopsy. Recent data suggest that the study of serum antigliadin, antireticulin and antiendomysium antibodies may possibly play the role. In this paper the working group on coeliac disease of the Groupe Francophone de Gastroentérologie et Nutrition Pédiatriques expresses its view on the place of the dosages of these antibodies in the diagnosis and follow up procedures of coeliac disease in infants and children. At the present time, although it allows a simplification of the procedures, these dosages are presently not sufficiently reliable to serve as a substitute of jejunal biopsy.
Olives
J P
JP
Service de médecine infantile D, CHU Purpan, Toulouse, France.
Baudon
J J
JJ
Dabadie
A
A
Fontaine
J L
JL
Lamireau
T
T
Morali
A
A
Rieu
D
D
Sarles
J
J
Schmitz
J
J
Touhami
M
M
D001323:Autoantibodies / Q000097:blood*; D015415:Biomarkers; D001706:Biopsy; D002446:Celiac Disease / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control; D002648:Child; D005500:Follow-Up Studies; D005903:Gliadin / Q000276:immunology*; D006801:Humans; D007583:Jejunum / Q000473:pathology; D008403:Mass Screening; D009130:Muscle, Smooth / Q000276:immunology*; D012155:Reticulin / Q000276:immunology*
D001323:Autoantibodies; D015415:Biomarkers; D012155:Reticulin; D005903:Gliadin
Anticorps antigladine, antiréticuline et antiendomysium: intérêt dans le diagnostic et le suivi de la maladie coeliaque chez l'enfant.